Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
quote
ABUS – Arbutus Biopharma Corporation –
ABUS – Arbutus Biopharma Corporation –
Quotes
Charts
News & Analysis for ABUS
Arbutus Biopharma Corporation (NASDAQ:ABUS) Files An 8-K Other Events
ME Staff 8-k
-
July 24, 2020
0
Arbutus Biopharma Corporation (NASDAQ:ABUS) Files An 8-K Other Events
ME Staff 8-k
-
May 18, 2020
0
Arbutus Biopharma Corporation (NASDAQ:ABUS) Files An 8-K Results of Operations and...
ME Staff 8-k
-
May 11, 2020
0
Arbutus Biopharma Corporation (NASDAQ:ABUS) Files An 8-K Other Events
ME Staff 8-k
-
March 27, 2020
0
Arbutus Biopharma Corporation (NASDAQ:ABUS) Files An 8-K Results of Operations and...
ME Staff 8-k
-
March 5, 2020
0
Arbutus Biopharma Corporation (NASDAQ:ABUS) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
February 19, 2020
0
Arbutus Biopharma Corporation (NASDAQ:ABUS) Files An 8-K Other Events
ME Staff 8-k
-
February 10, 2020
0
Arbutus Biopharma Corporation (NASDAQ:ABUS) Files An 8-K Results of Operations and...
ME Staff 8-k
-
January 13, 2020
0
Arbutus Biopharma Corp (NASDAQ:ABUS) gets downgraded to Neutral by Chardan Capital
ME Staff
-
October 4, 2019
0
Arbutus Biopharma Corporation (NASDAQ:ABUS) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
August 21, 2019
0
Arbutus Biopharma Corp (NASDAQ:ABUS) had its Buy rating reiterated by Chardan...
ME Staff
-
July 16, 2019
0
Arbutus Biopharma Corporation (NASDAQ:ABUS) Files An 8-K Entry into a Material...
ME Staff 8-k
-
July 3, 2019
0
The Increasing Problem of Substance Abuse by Traders
ME Staff
-
June 18, 2019
0
Arbutus Biopharma Corporation (NASDAQ:ABUS) Files An 8-K Submission of Matters to...
ME Staff 8-k
-
May 28, 2019
0
Arbutus Biopharma Corporation (NASDAQ:ABUS) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
March 15, 2019
0
Arbutus Biopharma Corporation (NASDAQ:ABUS) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
November 27, 2018
0
Arbutus Biopharma Corp (NASDAQ:ABUS) gets upgraded to Buy by B. Riley...
ME Staff
-
October 16, 2018
0
Arbutus Biopharma Corp (NASDAQ:ABUS) gets upgraded to Neutral by Wedbush with...
ME Staff
-
October 15, 2018
0
Load more